Pyxis Oncology, Inc. financial data

Symbol
PYXS on Nasdaq
Location
321 Harrison Avenue, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 618 % -21.5%
Debt-to-equity 37.2 % +43.5%
Return On Equity -102 % -182%
Return On Assets -74.4 % -159%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.3M shares +4.71%
Common Stock, Shares, Outstanding 62.1M shares +4.54%
Entity Public Float 183M USD +88.6%
Common Stock, Value, Issued 62K USD +5.09%
Weighted Average Number of Shares Outstanding, Basic 62.6M shares +3.03%
Weighted Average Number of Shares Outstanding, Diluted 62.6M shares +3.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.82M USD
Cost of Revenue 475K USD
Research and Development Expense 66M USD +17.2%
General and Administrative Expense 22M USD -16.8%
Operating Income (Loss) -106M USD -58.1%
Nonoperating Income (Expense) 7.23M USD -26.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22M USD -3.77%
Income Tax Expense (Benefit) 283K USD
Net Income (Loss) Attributable to Parent -97.1M USD -69.3%
Earnings Per Share, Basic -1 USD/shares -55.8%
Earnings Per Share, Diluted -1 USD/shares -55.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.92M USD -26%
Marketable Securities, Current 67.3M USD -49.3%
Cash, Cash Equivalents, and Short-term Investments 76.3M USD -47.3%
Accounts Receivable, after Allowance for Credit Loss, Current 3M USD
Other Assets, Current 674K USD +107%
Assets, Current 83.1M USD -44.2%
Property, Plant and Equipment, Net 8.46M USD -18.6%
Operating Lease, Right-of-Use Asset 11.6M USD
Intangible Assets, Net (Excluding Goodwill) 2.43M USD -89.7%
Assets 106M USD -45.9%
Accounts Payable, Current 9.76M USD +100%
Employee-related Liabilities, Current 3.98M USD -23.7%
Accrued Liabilities, Current 8M USD -43.1%
Contract with Customer, Liability, Current 7.66M USD
Liabilities, Current 19.4M USD -4.62%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 17.4M USD -8.57%
Liabilities 36.8M USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 69K USD -80.3%
Retained Earnings (Accumulated Deficit) -425M USD -29.6%
Stockholders' Equity Attributable to Parent 68.8M USD -55.2%
Liabilities and Equity 106M USD -45.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.5M USD -8.81%
Net Cash Provided by (Used in) Financing Activities 57.5M USD
Net Cash Provided by (Used in) Investing Activities 15.8M USD
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 62.1M shares +4.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.71M USD -137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.4M USD -23.2%
Deferred Tax Assets, Valuation Allowance 140M USD +17.5%
Deferred Tax Assets, Gross 145M USD +13.7%
Operating Lease, Liability 20.1M USD -5.77%
Payments to Acquire Property, Plant, and Equipment 237K USD -94.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.4M USD -71.1%
Lessee, Operating Lease, Liability, to be Paid 29.1M USD -9.87%
Property, Plant and Equipment, Gross 15.1M USD -2.21%
Operating Lease, Liability, Current 1.63M USD +17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.38M USD +2.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.28M USD +2.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.99M USD -17.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.47M USD +2.9%
Deferred Tax Assets, Operating Loss Carryforwards 78.2M USD +15.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.58M USD +2.94%
Operating Lease, Payments 3M USD 0%
Additional Paid in Capital 494M USD +2.59%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 552K USD -50.5%
Deferred Tax Assets, Net of Valuation Allowance 4.14M USD -45.7%
Share-based Payment Arrangement, Expense 12.5M USD -6.69%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%